Autopsy report · NCT04123574

A Pilot Study of BXCL701 in Patients With Pancreatic Cancer

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“No longer relevant to field”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Early Phase 1
Sponsor: BioXcel Therapeutics Inc
Sponsor type: Industry
Conditions: Cancer of Pancreas; Cancer of the Pancreas; Neoplasms, Pancreatic; Pancreas Cancer; Pancreatic Cancer
Interventions: Talabostat Mesylate
Participants: 0
Sites: 2
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.